Publication details
Prolactin levels in risperidone treatment of first episode schizophrenia.
| Basic information | |
|---|---|
| Original title: | Prolactin levels in risperidone treatment of first episode schizophrenia. |
| Authors: | Eva Češková, Radovan Přikryl, Tomáš Kašpárek, Marta Ondrušová |
| Further information | |
|---|---|
| Citation: | ČEŠKOVÁ, Eva, Radovan PŘIKRYL, Tomáš KAŠPÁREK and Marta
ONDRUŠOVÁ. Prolactin levels in risperidone treatment of first
episode schizophrenia. (Prolactin levels in risperidone
treatment of first episode schizophrenia.). International
Journal of Psychiatry in Clinical Practice, 2003, vol. 2003, No
8, p. 1 -6. ISSN 1365 -1501.Export BibTeX |
| Original language: | Czech |
| Field: | Psychiatry, sexuology |
| Type: | Article in Periodical |
| Keywords: | prolactin; risperidone; schizophrenia |
Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.
Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.
Related projects:












